The Office of Research and Engagement and NeuroNET research center are co-sponsoring a day-long symposium on Alzheimer’s Disease research Tuesday, January 19 in Blount Hall that will feature speakers from the University of Washington St. Louis and the University of Toronto as well as UT and UTMC.
The symposium, conceived by Lynda Hardy, associate dean for research in the College of Nursing,Georgia Tourassi, director of the Biomedical Science and Engineering Center at Oak Ridge National Laboratory, and Laura Findeiss, associate professor and chair of the Department of Radiology at the UT Graduate School of Medicine, due to their interest in the disease.
“Many people do not understand what Alzheimer’s Disease is, how it is diagnosed, how it is treated, and most of all, the effect it has on the individual and their family,” said Hardy. “It is our hope that this presentation will generate interest from all collaborating parties, so that we can develop additional interdisciplinary research towards knowledge and interventions to assist in battling this disease.”
Guest Speaker Information
Beau Ances, a neuroscientist and practicing physician neurologist at Washington Hospital St. Louis. The Ances Laboratory is interested in dementias including Alzheimer’s Disease and Rapidly Progressive Dementias such as Cruetzfeld Jacob Disease. This group is interested in discovering early neuroimaging biomarkers of these diseases.
Kieran Murphy, MD is the Vice Chair and Chief of Medical Imaging at the University of Toronto. He was previously at the Johns Hopkins Hospital as the Director of Interventional Neuroradiology. Dr. Murphy served as the Director of Research in the neuroradiology section of the Albany Medical College in New York for seven years and is one of the most innovative specialists in the use of radiology guidance in the treatment of vascular brain and spine disorders.
Alzheimer’s Disease Symposium Agenda
Tuesday, January 19, 2016
Blount Hall, Room A004
Lyn Hardy, PhD, RN
9:05 — Unraveling the Mysteries of Alzheimer’s Disease: Potential Role for Biomarker
Beau Ances, MD, PhD, University of Washington St. Louis
10:05— Imaging of Alteration of Consciousness
Kieran Murphy, MB FRCPC FSIR
11:05– 12:05— Unleashing the Power of Big Data and HPC for Alzheimer’s Research
Gina Tourassi, PhD
12:05—12:30— UT & UTMC Research
Peptide Theranostics for AD and Abeta Amyloidosis
Jonathan Wall, PhD
Detection of Cognitive Deficits Via Advanced Analysis of EEG
Xiaopeng Zhao, PhD
12:30—1:00 Panel Discussion